Alterity Therapeutics (ATHE) Leases (2020 - 2025)

Alterity Therapeutics' Leases history runs 6 years deep, the most recent figure standing at $61822.5 for Q4 2025.

• In Q4 2025, Leases fell 5.89% year-over-year to $61822.5; the TTM figure through Dec 2025 stood at $61822.5 (down 5.89% YoY), while the FY2025 annual figure was $96914.2, up 6163.48% from the prior year.
• Leases was $61822.5 for Q4 2025 at Alterity Therapeutics, down from $96914.2 in the prior quarter.
• In the past five years, Leases ranged from a high of $138408.8 in Q2 2023 to a low of $29896.9 in Q4 2021.
• Historically, Leases has averaged $78316.3 across 5 years, with a median of $74380.8 in 2022.
• The sharpest annual moves came in 2021 and 2024: Leases jumped 372.86% in 2021, then tumbled 32.88% in 2024.
• A 5-year view of Leases shows it stood at $29896.9 in 2021, then soared by 90.94% to $57084.7 in 2022, then soared by 71.45% to $97869.9 in 2023, then sank by 32.88% to $65695.2 in 2024, then slipped by 5.89% to $61822.5 in 2025.
• The last three Leases figures came in at $61822.5 (Q4 2025), $96914.2 (Q2 2025), and $65695.2 (Q4 2024), per Business Quant data.